The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing the public of the presence falsified Lins Meropenem Injection in Abuja. The falsified product was administered to a patient in a clinic within FCT, Abuja.
Genuine Meropenem injection is an antibiotic used to treat skin and abdominal (stomach area) infections caused by bacteria and meningitis (infection of the membranes that surround the brain and spinal cord) in adults and children 3 months of age and older.
Risk Statement
The illegal marketing of medicines or counterfeit medicines poses a risk to the health of people, since by not complying with the regulatory provisions, the safety, quality and efficacy of the products are not guaranteed.
Product details
The details of the product are as follows;
Product Name: LINS Meropenem for Injection USP 1000mg
Product Manufacturer: Keylink Global, Exim Private Limited, Plot No. 150/1, 3rd Floor, Shipra Path Road, Jaipur, Rajasthan, India.
Batch Number: C1009312
Manufacturing date: 12/2023
Expiry date: 11/2026
Product picture
All NAFDAC zonal directors and state coordinators have been directed to carry out surveillance and mop up the falsified product within the zones and states.
Importers, distributors, retailers, healthcare professionals and caregivers are hereby advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale and use of the substandard and falsified product. All medical products must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked.
Healthcare professionals and consumers are advised to report any suspicion of sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, NAFDAC on 0800-162-3322 or via email: sf.alert@nafdac.gov.ng
Similarly, healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of medicinal products or devices to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng or via the Med- safety application available for download on android and IOS stores or via e-mail on pharmacovigilance@nafdac.gov.ng
Furthermore, note that this notice will be uploaded to the WHO Global Surveillance and Monitoring System (GSMS).
NAFDAC………. Customer-focused, Agency-minded!!!
